US Patent Issued to CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION on June 30 for "Composition for preventing, treating or alleviating diabetes, comprising LGI3-derived peptide as an active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,667,602, issued on June 30, was assigned to CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seoul, South Korea).

"Composition for preventing, treating or alleviating diabetes, comprising LGI3-derived peptide as an active ingredient" was invented by Hye-Young Yun (Seoul, South Korea) and Dong-Seok Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition and the like, for preventing, treating or alleviating diabetes, comprising an LGI3-derived peptide as an effective component. The composition comprising, as an active ingredient, an LGI3-derived peptide comprising an amino acid se...